^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Onzeald (etirinotecan pegol)

    i
    Associations
    News

    Trials

    Company:
    Nektar Therap
    Drug class:
    Topoisomerase I inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine (ATTAIN) (NCT02915744)
    Phase 3
    Nektar Therapeutics
    Completed
    Last update posted :
    04/14/2023
    Initiation :
    11/01/2016
    Primary completion :
    07/01/2020
    Completion :
    07/01/2020
    HER-2
    |
    gemcitabine • docetaxel • capecitabine • albumin-bound paclitaxel • irinotecan • Halaven (eribulin mesylate) • vinorelbine tartrate • Ixempra (ixabepilone) • Onzeald (etirinotecan pegol)
    NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer (NCT00856375)
    Phase 2
    Nektar Therapeutics
    Completed
    Last update posted :
    07/12/2021
    Initiation :
    12/01/2008
    Primary completion :
    07/01/2014
    Completion :
    12/01/2014
    KRAS • RAS
    |
    KRAS mutation • RAS mutation
    |
    irinotecan • Onzeald (etirinotecan pegol)